Approvals expand Amneal’s biosimilars portfolioCompany expects to commercialize six biosimilars across eight presentations by ...
3h
mAbxience and Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia® and XGEVA®
Abxience, a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma, and Amneal Pharmaceuticals, Inc. ("Amneal" or the "Company") (NASDAQ: AMRX), today announced that the U.S.
Soy Nómada on MSN
The 7 common cat diseases that every pet owner should know to protect their feline health
From minor infections to chronic conditions, understanding the most common cat illnesses is essential for responsible pet ...
The Spicy Chefs on MSN
Discard your cookware if it's any of these lead-leeching brands, FDA says
Your cookware has one job: to allow you to safely cook food. However, several imported brands may actually be putting you at ...
WICHITA, Kan. (KSNW) – Tanganyika Wildlife Park announced Sunday that their beloved sloth, Chewie, has passed away.
Proteomics International Laboratories Ltd (ASX: PIQ) has announced the publication of a peer-reviewed Australian clinical ...
Chronic kidney disease significantly impacts cardiovascular health, highlighting the need for effective screening and ...
Callout: “If AI set the future-tech agenda, the HDF vs. HDx debate owned the coffee breaks.”Kidney care is entering an era ...
Discover effective strategies for engaging clinicians in population health and improving chronic kidney disease management ...
STOCKHOLM, Sweden, December 22, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines has signed a non-binding letter of intent (LOI) with Novakand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback